Man Group’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $220K | Buy |
11,772
+1,501
| +15% | +$28.1K | ﹤0.01% | 1817 |
|
|
2025
Q1 | $185K | Sell |
10,271
-7,885
| -43% | -$142K | ﹤0.01% | 1810 |
|
|
2024
Q4 | $305K | Sell |
18,156
-7,442
| -29% | -$125K | ﹤0.01% | 1631 |
|
|
2024
Q3 | $414K | Buy |
25,598
+149
| +0.6% | +$2.41K | ﹤0.01% | 1565 |
|
|
2024
Q2 | $209K | Buy |
25,449
+13,349
| +110% | +$110K | ﹤0.01% | 1742 |
|
|
2024
Q1 | $179K | Buy |
+12,100
| New | +$179K | ﹤0.01% | 1889 |
|
|
2023
Q2 | – | Hold |
0
| – | -$189K | – | 2130 |
|
|
2023
Q1 | – | Sell |
-13,011
| Closed | -$195K | – | 1792 |
|
|
2022
Q4 | $195K | Buy |
13,011
+10,465
| +411% | +$157K | ﹤0.01% | 1771 |
|
|
2022
Q3 | $30K | Buy |
+2,546
| New | +$30K | ﹤0.01% | 1877 |
|
|
2019
Q4 | – | Sell |
-1,100
| Closed | -$21K | – | 1885 |
|
|
2019
Q3 | $21K | Buy |
+1,100
| New | +$21K | ﹤0.01% | 1754 |
|
|
2018
Q3 | – | Sell |
-4,400
| Closed | -$125K | – | 2184 |
|
|
2018
Q2 | $125K | Buy |
+4,400
| New | +$125K | ﹤0.01% | 2048 |
|